How Tariffs Impact Access to Medicines
Import duties on pharmaceutical manufacturing inputs such as APIs cost patients US$1.2bn in the US and US$1.1bn in the EU, find Philipp Lamprecht and Matthias Bauer in this new Geneva Network working paper.
Tariffs are hurting patients – and hampering the fight against Covid
While researchers in universities and private-sector laboratories work round-the-clock for new treatments and vaccines for Covid-19, physicians rely on a broad cabinet of older medicines to help patients through their darkest hour.
Abolishing pharmaceutical and vaccine tariffs to promote access
The Covid-19 pandemic has illustrated the importance of global trade for access to all kinds of medical supplies, with many jurisdictions suffering shortages of essential medical goods as a result of various trade barriers.
Trade Barriers Stand in the Way of Defeating COVID-19
At the 73rd World Health Assembly earlier this week, public health officials from dozens of countries gathered — virtually, of course — to discuss strategies to defeat COVID-19.